Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03358888 · ClinicalTrials.gov registry record · NA
Prolonged Multimodal Analgesia for Post-Discharge Pain Control After Primary Total Hip Arthroplasty
A NA study, sponsored by Rothman Institute Orthopaedics.
- Completed
- Registry status
- NA
- Development phase
- 228
- Enrollment target
NCT03358888: Completed NA study, sponsored by Rothman Institute Orthopaedics.
NCT03358888 is a NA study that has completed, run by Rothman Institute Orthopaedics. The registered enrollment target is 228 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03358888, a NA study, has completed, sponsored by Rothman Institute Orthopaedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 228 participants
- Enrollment target
Study Summary
This is a prospective, three-arm, comparative study with a provider-crossover design. The first arm will comprise the standard of care pain regimen after discharge, which comprises PRN oxycodone, tramadol, and acetaminophen. The second arm will comprise a multimodal pain regimen; however, patients will still be routinely provided PRN oxycodone and tramadol to use on an as needed basis. The third arm will comprise a multimodal pain management protocol, which does not routinely allow for opioid consumption. However, patients will be provided a one week supply of oxycodone and tramadol for emergency pain relief only.
Interventions
- DRUG Standard of Care
- DRUG Multi-modal with as needed opioids
- DRUG Multi-modal with one week of opioids offered
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2017-06-05 |
| Est. Completion | 2018-02-28 |
| Phase | NA |
What the finished NCT03358888 record still lists
NCT03358888 is an interventional study that assigns participants to a tested intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 3 interventions - of which Standard of Care is the first listed.
NCT03358888 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03358888 about?
NCT03358888 is a clinical study titled "Prolonged Multimodal Analgesia for Post-Discharge Pain Control After Primary Total Hip Arthroplasty". This is a prospective, three-arm, comparative study with a provider-crossover design. The first arm will comprise the standard of care pain regimen after discharge, which comprises PRN oxycodone, tramadol, and acetaminophen. The second arm will comprise a multimodal pain regimen; however, patients w...
What is the current status of trial NCT03358888?
This trial is currently completed. It is a NA study. The enrollment target is 228 participants. The study started on 2017-06-05. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT03358888?
The interventions under investigation include: Standard of Care (DRUG), Multi-modal with as needed opioids (DRUG), Multi-modal with one week of opioids offered (DRUG).
Who is sponsoring clinical trial NCT03358888?
This trial is sponsored by Rothman Institute Orthopaedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03358888's enrollment target sits among peer trials
228 468th of 2000 higher than 1,530 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
- NCT05547698 · 228 participants · NA
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
- NCT05630963 · 228 participants
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
- NCT06073665 · 228 participants · Phase 4
Dosing of LT4 in Older Individuals
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI